| Loss of p53 drives neuron reprogramming in head and neck cancer M Amit, H Takahashi, MP Dragomir, A Lindemann, FO Gleber-Netto, ... Nature 578 (7795), 449-454, 2020 | 299 | 2020 |
| Phase II trial of trastuzumab and docetaxel in patients with human epidermal growth factor receptor 2–positive salivary duct carcinoma H Takahashi, Y Tada, T Saotome, K Akazawa, H Ojiri, C Fushimi, ... Journal of Clinical Oncology 37 (2), 125-134, 2019 | 197 | 2019 |
| A prospective phase II study of combined androgen blockade in patients with androgen receptor-positive metastatic or locally advanced unresectable salivary gland carcinoma C Fushimi, Y Tada, H Takahashi, T Nagao, H Ojiri, T Masubuchi, ... Annals of Oncology 29 (4), 979-984, 2018 | 173 | 2018 |
| Targeting the DNA Damage Response in OSCC with TP53 Mutations A Lindemann, H Takahashi, AA Patel, AA Osman, JN Myers Journal of dental research 97 (6), 635-644, 2018 | 140 | 2018 |
| Induction chemotherapy response as a guide for treatment optimization in sinonasal undifferentiated carcinoma M Amit, AS Abdelmeguid, T Watcherporn, H Takahashi, S Tam, D Bell, ... Journal of Clinical Oncology 37 (6), 504-512, 2019 | 130 | 2019 |
| Radioiodine-refractory thyroid cancer: molecular basis of redifferentiation therapies, management, and novel therapies M Aashiq, DA Silverman, S Na’ara, H Takahashi, M Amit Cancers 11 (9), 1382, 2019 | 128 | 2019 |
| Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity N Tanaka, AA Osman, Y Takahashi, A Lindemann, AA Patel, M Zhao, ... Oral oncology 87, 49-57, 2018 | 118 | 2018 |
| Clinicopathological significance of androgen receptor, HER2, Ki-67 and EGFR expressions in salivary duct carcinoma T Masubuchi, Y Tada, S Maruya, Y Osamura, S Kamata, K Miura, ... International journal of clinical oncology 20, 35-44, 2015 | 117 | 2015 |
| COTI-2, a novel thiosemicarbazone derivative, exhibits antitumor activity in HNSCC through p53-dependent and-independent mechanisms A Lindemann, AA Patel, NL Silver, L Tang, Z Liu, L Wang, N Tanaka, ... Clinical Cancer Research 25 (18), 5650-5662, 2019 | 103 | 2019 |
| JunB promotes cell invasion, migration and distant metastasis of head and neck squamous cell carcinoma H Hyakusoku, D Sano, H Takahashi, T Hatano, Y Isono, S Shimada, Y Ito, ... Journal of Experimental & Clinical Cancer Research 35, 1-12, 2016 | 74 | 2016 |
| Gain-of-function mutant p53 promotes the oncogenic potential of head and neck squamous cell carcinoma cells by targeting the transcription factors FOXO3a and FOXM1 N Tanaka, M Zhao, L Tang, AA Patel, Q Xi, HT Van, H Takahashi, ... Oncogene 37 (10), 1279-1292, 2018 | 58 | 2018 |
| Antitumor effects of lapatinib (GW572016), a dual inhibitor of EGFR and HER-2, in combination with cisplatin or paclitaxel on head and neck squamous cell carcinoma N Kondo, M Tsukuda, Y Ishiguro, M Kimura, K Fujita, A Sakakibara, ... Oncology reports 23 (4), 957-963, 2010 | 47 | 2010 |
| Prognostic and histogenetic roles of gene alteration and the expression of key potentially actionable targets in salivary duct carcinomas T Shimura, Y Tada, H Hirai, D Kawakita, S Kano, K Tsukahara, A Shimizu, ... Oncotarget 9 (2), 1852, 2018 | 43 | 2018 |
| Multicentre, retrospective study of the efficacy and safety of nivolumab for recurrent and metastatic salivary gland carcinoma K Niwa, D Kawakita, T Nagao, H Takahashi, T Saotome, M Okazaki, ... Scientific reports 10 (1), 16988, 2020 | 36 | 2020 |
| Classification of tumors by imaging diagnosis and preoperative fine‐needle aspiration cytology in 120 patients with tumors in the parapharyngeal space T Matsuki, K Miura, Y Tada, T Masubuchi, C Fushimi, C Kanno, ... Head & Neck 41 (5), 1277-1281, 2019 | 36 | 2019 |
| Prognostic performance of the American Joint Committee on Cancer 8th edition of the TNM staging system in patients with early oral tongue cancer M Amit, S Tam, H Takahashi, KY Choi, M Zafereo, D Bell, RS Weber Head & Neck 41 (5), 1270-1276, 2019 | 32 | 2019 |
| Replication stress leading to apoptosis within the S-phase contributes to synergism between vorinostat and AZD1775 in HNSCC harboring high-risk TP53 mutation N Tanaka, AA Patel, L Tang, NL Silver, A Lindemann, H Takahashi, ... Clinical Cancer Research 23 (21), 6541-6554, 2017 | 30 | 2017 |
| Identification of human papillomavirus (HPV) 16 DNA integration and the ensuing patterns of methylation in HPV‐associated head and neck squamous cell carcinoma cell lines T Hatano, D Sano, H Takahashi, H Hyakusoku, Y Isono, S Shimada, ... International journal of cancer 140 (7), 1571-1580, 2017 | 29 | 2017 |
| Salvage chemotherapy after nivolumab for recurrent or metastatic head and neck carcinoma C Fushimi, I Okamoto, T Matsuki, T Masubuchi, T Okada, H Sato, ... Anticancer research 40 (9), 5277-5283, 2020 | 28 | 2020 |
| The applicability of new TNM classification for humanpapilloma virus-related oropharyngeal cancer in the 8th edition of the AJCC/UICC TNM staging system in Japan: A single … D Sano, K Yabuki, Y Arai, T Tanabe, Y Chiba, G Nishimura, H Takahashi, ... Auris Nasus Larynx 45 (3), 558-565, 2018 | 27 | 2018 |
Antje LindemannThe University of Texas MD Anderson Cancer Center, Department of Head and Neck Surgery在 mdanderson.org 的电子邮件经过验证
